OPRM1 and Pain: DOR ligands are characterized by lower antinociceptive effect as compared to MOR, but the increased trafficking of DOR and its hetero-oligomers with MOR during central sensitization indicate MOR-DOR as a strategic target for neuropathic pain [20].